Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

NCT01893320 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Vosaroxin
DRUG: Decitabine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]